Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans

doi:10.1083/jcb.72.1.174

This Article

	Full Text (PDF, 2033K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Davidse, L. C.
	Articles by Flach, W.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Davidse, L. C.
	Articles by Flach, W.


Social Bookmarking

	What's this?

ARTICLES

Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans

LC Davidse and W Flach

The antimitotic compound methyl benzimidazol-2-yl carbamate (MBC) formed a complex in vitro with a protein present in mycelial extracts of fungi. The binding protein of Aspergillus nidulans showed a set of properties which is unique for tubulin. Binding occurred rapidly at 4 degrees C and was competitively inhibited by oncodazole and colchicine. Other inhibitors of microtubule function such as podophyllotoxin, vinblastine sulfate, melatonin, and griseofulvin did not interfere with binding of MBC. Electrophoretic analysis of partially purified preparations of the binding protein revealed the presence of proteins with similar mobilities as mammalian tubulin monomers. Hence it is concluded that the binding protein is identical with fungal tubulin. The effect of MBC on mycelial growth of mutant strains of A. nidulans was positively correlated with the affinity of the binding sites for this compound. The apparent binding constant for MBC and tubulin from a wild type was estimated at 4.5 X 10(5), from a resistant strain at 3.7 X 10(4), and from a strain with increased sensitivity to MBC at 1.6 X 10(6) liters/mol. Mutants showing resistance and increased sensitivity to MBC are candidates to have alterations in tubulin structure. Affinity of tubulin for MBC is probably a common mechanism of resistance to this compound in fungi. Low affinity of tubulin for MBC is probably a common mechanism of resistance binding constant of 2.5 X 10(3) liters/mol.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Yenjerla, M., Cox, C., Wilson, L., Jordan, M. A. (2009). Carbendazim Inhibits Cancer Cell Proliferation by Suppressing Microtubule Dynamics. J. Pharmacol. Exp. Ther. 328: 390-398 [Abstract] [Full Text]
Yin, S., Cabral, F., Veeraraghavan, S. (2007). Amino acid substitutions at proline 220 of {beta}-tubulin confer resistance to paclitaxel and colcemid. Molecular Cancer Therapeutics 6: 2798-2806 [Abstract] [Full Text]
Vassal, E., Barette, C., Fonrose, X., Dupont, R., Sans-Soleilhac, E., Lafanechere, L. (2006). Miniaturization and Validation of a Sensitive Multiparametric Cell-Based Assay for the Concomitant Detection of Microtubule-Destabilizing and Microtubule-Stabilizing Agents. J Biomol Screen 11: 377-389 [Abstract]
Ma, Z., Yoshimura, M. A., Michailides, T. J. (2003). Identification and Characterization of Benzimidazole Resistance in Monilinia fructicola from Stone Fruit Orchards in California. Appl. Environ. Microbiol. 69: 7145-7152 [Abstract] [Full Text]
Woyke, T., Roberson, R. W., Pettit, G. R., Winkelmann, G., Pettit, R. K. (2002). Effect of Auristatin PHE on Microtubule Integrity and Nuclear Localization in Cryptococcus neoformans. Antimicrob. Agents Chemother. 46: 3802-3808 [Abstract] [Full Text]
Correa, L. M., Nakai, M., Strandgaard, C. S., Hess, R. A., Miller, M. G. (2002). Microtubules of the Mouse Testis Exhibit Differential Sensitivity to the Microtubule Disruptors Carbendazim and Colchicine. Toxicol Sci 69: 175-182 [Abstract] [Full Text]
Hari, M., Wang, Y., Veeraraghavan, S., Cabral, F. (2002). Mutations in {alpha}- and {beta}-Tubulin That Stabilize Microtubules and Confer Resistance to Colcemid and Vinblastine. Molecular Cancer Therapeutics 2: 597-605 [Abstract] [Full Text]
Winder, B. S., Strandgaard, C. S., Miller, M. G. (2001). The Role of GTP Binding and Microtubule-Associated Proteins in the Inhibition of Microtubule Assembly by Carbendazim. Toxicol Sci 59: 138-146 [Abstract] [Full Text]
de Stoppelaar, J. M., van de Kuil, T., Verharen, H. W., Hokse, H., Opperhuizen, A., Mohn, G. R., van Benthem, J., Hoebee, B. (2000). In vivo cytokinesis blocked micronucleus assay with carbendazim in rat fibroblasts and comparison with in vitro assays. Mutagenesis 15: 155-164 [Abstract] [Full Text]
de Stoppelaar, J. M., van de Kuil, T., Bedaf, M., Verharen, H. W., Slob, W., Mohn, G. R., Hoebee, B., van Benthem, J. (1999). Increased frequencies of diploid sperm detected by multicolour FISH after treatment of rats with carbendazim without micronucleus induction in peripheral blood erythrocytes. Mutagenesis 14: 621-632 [Abstract] [Full Text]